| Period Ending | Mar 30, 2013 |
|---|
|
Total Revenue
|
5,310,000
| | Cost of Revenue | 3,735,000 | | |
Gross Profit
|
1,575,000
| |
|
Operating Expenses |
|
Research Development | 152,000 |
|
Selling General and Administrative | 958,000 |
|
Non Recurring |
-
|
|
Others |
-
|
|
|
|
Total Operating Expenses |
-
| | | |
Operating Income or Loss
|
465,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 10,000 |
|
Earnings Before Interest And Taxes | 475,000 |
|
Interest Expense | 75,000 |
|
Income Before Tax | 400,000 |
|
Income Tax Expense | 20,000 |
|
Minority Interest | (2,000) |
|
|
|
Net Income From Continuing Ops | 378,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
378,000
| | Preferred Stock And Other Adjustments |
-
| | |
Net Income Applicable To Common Shares
|
378,000
|
|
1.35%